Objective Peripheral Arterial Disease (PAD) is caused by the deposition of fatty material on the inner walls of peripheral arteries causing reducing perfusion and local nutrition to the muscles and skin. The condition affect 202 million people globally and is increasing at a rate of 20% per annum due to an aging population and epidemic growth of diabetes. The social costs amounts to $210 - 380 billion per annum. Behavioural changes such as smoking cessation, healthy nutrition and exercise is recommended to reduce impact and risk. When the condition worsens, patients ability to walk and exercise is reduced. When disease progress to critical limb ischemia (unbearable pain and chronic wounds), the patients follow a trajectory towards costly vascular surgery or amputation.FlowOx targets the gap in care with a patented, cost effective and clinically promising home treatment solution. In order to secure the successful introduction of FlowOx into the market by 2020, resources are required to fill the following gaps in innovation:1) strong clinical evidence of efficacy 2) health economic assessment 3) design for large scale manufacturing and 4) a validated commercial model Germany, UK and Scandinavia. These 4 challenges will be addressed in the FlowOx project over a 30-month period. The Fast Track to Innovation Pilot program was selected to support a resource demanding and technically challenging stage of the product roadmap. The support enables Otivio to join forces with a medical device manufacturer, Innokas Medical, Finland, and UK based Univ. of Salford and Univ. of Bangor with extensive experience in clinical and health economic studies. The FlowOx project enables Otivio and Innokas to enter the world-wide PAD market, gaining a strong market positon with a home care device for PAD treatment and expected sales of over €220 million within 5 years of launch. Fields of science medical and health sciencesclinical medicinesurgerymedical and health sciencesclinical medicineendocrinologydiabetesmedical and health scienceshealth sciencesnutritionmedical and health sciencesclinical medicineperipheral vascular diseasesocial scienceseconomics and businessbusiness and managementcommerce Programme(s) H2020-EC - Horizon 2020 Framework Programme Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2. - PRIORITY 'Industrial leadership' Topic(s) FTIPilot-01-2016 - Fast Track to Innovation Pilot Call for proposal H2020-FTIPilot-2016 See other projects for this call Sub call H2020-FTIPilot-2016-1 Funding Scheme IA - Innovation action Coordinator OTIVIO AS Net EU contribution € 876 000,00 Address GAUSTADALLEEN 21 0349 OSLO Norway See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Norge Oslo og Viken Oslo Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost € 1 251 428,58 Participants (3) Sort alphabetically Sort by Net EU contribution Expand all Collapse all INNOKAS MEDICAL OY Finland Net EU contribution € 680 750,00 Address VIHIKARI 10 90440 Kempele See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Manner-Suomi Pohjois- ja Itä-Suomi Pohjois-Pohjanmaa Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost € 972 500,00 THE UNIVERSITY OF SALFORD United Kingdom Net EU contribution € 375 000,00 Address THE CRESCENT 43 M5 4WT Salford See on map Region North West (England) Greater Manchester Greater Manchester South West Activity type Higher or Secondary Education Establishments Links Contact the organisation Opens in new window Website Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost € 375 000,00 BANGOR UNIVERSITY United Kingdom Net EU contribution € 148 750,00 Address COLLEGE ROAD LL57 2DG Bangor See on map Region Wales West Wales and The Valleys Gwynedd Activity type Higher or Secondary Education Establishments Links Contact the organisation Opens in new window Website Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost € 148 750,00